Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
Date:3/5/2009

VANCOUVER, March 5 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced its financial results for the fourth quarter and year ended December 31, 2008.

"During 2008 we achieved solid sales results in our Medical Products Business and were able to sustain progress on our most important new technology initiatives despite a challenging year for TAXUS," said Dr. William Hunter, President and CEO of Angiotech. "Not only did we increase Medical Products sales compared to 2007, but we were able to achieve this growth while making reductions to our operating expenses. This has been a challenging year with many factors including the turmoil in the capital and credit markets impacting our company, and under those circumstances I am proud of the results our team was able to deliver in 2008."

    Fourth Quarter Financial Highlights

    Total revenue was $62.1 million.

    -   Net product sales were $46.1 million.

    -   Royalty revenue was $15.7 million.

    -   Adjusted EBITDA (earnings before interest, taxes, depreciation and
        amortization, adjusted to exclude certain non-cash and non-recurring
        items) was $10.3 million.

    -   Research and development expenses were $7.7 million, and as adjusted
        to exclude non-cash stock-based compensation expenses and non-
        recurring termination related costs were $6.9 million. These results
        compare to $10.7 million and $8.8 million, respectively, in the third
        quarter of 2008, reflecting a reduction in expenses of 21.6% in a
        single quarter on an adjusted basis. This reduction is in addition to
        the 49% reduction in research and development expenses already
        reported in the third quarter as compared to the second quarter of
        2008.

    -   Selling, general and administ
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
2. Angiotech Pharmaceuticals announces time change of conference call and webcast
3. Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners
4. Angiotech Announces Webcast and Call-in Numbers for Annual and Special General Meeting of Shareholders
5. Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
6. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
7. Angiotech wins before the UK House of Lords
8. Angiotech to Establish Separate Operating and Royalty Businesses
9. Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
10. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
11. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Clintrax Global, Inc., a ... Raleigh, NC , recently announced ... Vice President of Administration. As ... corporate processes, including their alignment with company objectives ... worked as an HR executive, specializing in needs ...
(Date:8/20/2014)... often have it that American Indians largely were wiped ... influenza and tuberculosis brought to the New World by ... 20 million people lived in the Americas shortly before ... killed by European diseases., But new research led by ... Johannes Krause of the University of Tubingen in Germany ...
(Date:8/20/2014)... , Aug. 20, 2014 Neurotrope, ... host a conference call to provide an update ... p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. and ... Live web cast: www.neurotropebioscience.com , under "Investor Relations"The ... after completion through September 2, 2014 at (888) ...
(Date:8/20/2014)... , Aug. 20, 2014  Decision Resources Group finds that the ... Russia , India and ... in 2013, roughly equal to the size of the ... BRIC market will experience much faster growth as a result of ... Other key findings from Decision Resources Group,s coverage of ...
Breaking Biology Technology:Clintrax Global, Inc. Announces Addition to Executive Team 2Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3Neurotrope To Host Conference Call 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3
... GlaxoSmithKline plc (LSE/NYSE: GSK ) announced ... its wholly-owned subsidiary Gemstone Acquisition Corporation for shares of ... GNLB ). The tender offer expired at 12:00 midnight, ... depositary for the tender offer has advised GSK that ...
... 7 Intradigm Corporation, a leading,developer of targeted, ... company has closed the final tranche of its ... million tranche, with,existing investor, Lilly Ventures, also participating. ... Series B financing to $21.4 million. Intradigm ...
... 7 Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: CTIC) ... Listing Qualifications Panel has granted CTI,s request to transfer,the ... Market to The NASDAQ,Capital Market, which will be effective ... CTI,s shares will continue to trade under the ticker ...
Cached Biology Technology:GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc. 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 2Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market 3
(Date:8/21/2014)... scientists including researchers from the University of Georgia recently published ... the journal Science . Their discovery paves the way ... in farming and industry. , Canola is grown across ... crop is increasingly cultivated in Georgia. Canola oil used for ... fat and rich supply of omega-3 fatty acids, but the ...
(Date:8/21/2014)... in smog-producing toxins in past decade, GTA still ... shows that while the Greater Toronto Area (GTA) ... contribute to smog, the city continues to violate ... which can cause or aggravate health problems such ... by a set of complex photochemical reactions involving ...
(Date:8/21/2014)... of American singles found that during sex with ... rates. On average, men experience orgasm 85.1 percent ... little difference. For women, however, orgasm occurrence is ... percent of the time during sex with a ... women,s sexual orientation, with lesbian women experiencing orgasm ...
Breaking Biology News(10 mins):Canola genome sequence reveals evolutionary 'love triangle' 2Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canada's standards for ozone air pollution 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 2Orgasm rates for single women less predictable than men's, vary by sexual orientation 3Orgasm rates for single women less predictable than men's, vary by sexual orientation 4
... and evolution of every living organism. In plants, the general ... growing down, into the soil, and their stems respond negatively, ... plants sense gravity and how do they direct or signal ... botanists understand a great deal about how this works, a ...
... Educational Research Association (AERA) is proud to announce the ... Education, a volume aimed at educators, researchers, policy makers, ... issues. This book is published by Routledge Publishers on ... on environmental education could not come at a better ...
... Bethesda, MD The Federation of American Societies ... registration for the Science Research Conference (SRC): Genetic ... Science Research Conference on Genetic Recombination & Genome ... and representing all leading model systems in the ...
Cached Biology News:How plants sense gravity -- a new look at the roles of genetics and the cytoskeleton 2How plants sense gravity -- a new look at the roles of genetics and the cytoskeleton 3AERA announces publication of the 'International Handbook of Research on Environmental Education' 2
... General description: self locking design in ... a new product number, created to ... showing no availability yet, please order ... or contact customer service for assistance. ...
... Arabidopsis 2 Oligo Microarray Kit (V2), 22K is ... and stress response. Each microarray contains content derived ... Institute for Genomic Research (TIGR) and represents 21,500 ... 5 standard 1 x 3? glass slides each ...
... of poor quality running into billions ... are under increasing pressure to reduce ... the microscopic distribution of ingredients is ... such as dissolution, stability, bio-availability and ...
... allows a rapid and efficient immunoprecipitation ... protein. The immunoprecipitation is performed with ... highly specific monoclonal antibody covalently attached ... affinity resin allows an efficient binding ...
Biology Products: